-
Healing Through ArtThe Breast Cancer Art Project encourages breast cancer patients and survivors to produce—and share—art about their cancer experiences.
by Ashley P. Taylor
-
Brain Cancer Patients Make ConnectionsAn app developed for glioblastoma patients allows them to track their symptoms and contribute to research.
by Brad Jones
-
Paying for Tumor TestingA recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.
by Brad Jones
-
AACR Annual Meeting 2018A roundup of news from the American Association for Cancer Research Annual Meeting 2018.
-
The Ins and Outs of Tumor TestingIn a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
-
The Many Faces of Patient AdvocacyAdvocates shared their stories and projects at the AACR Annual Meeting.
by Kate Yandell
-
Focusing on the FundamentalsNational Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency.
by Marci A. Landsmann
-
A Response to RoadblocksThe Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
-
Supporting SurvivorsPanel of experts discuss survivorship challenges and potential areas for study.
by Marci A. Landsmann
-
Artificial Intelligence Characterizes CancerAt the AACR Annual Meeting 2018, researchers at Google compared the speed and accuracy of human pathologists and computer algorithms in diagnosing and grading cancer.
by Kevin McLaughlin
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
